Proton Pump Inhibitor class drugs

21 results

  • aciphex

    (rabeprazole sodium)
    Waylis Therapeutics LLC
    ACIPHEX is indicated for the healing and symptomatic relief of erosive or ulcerative GERD, maintenance of GERD healing, treatment of symptomatic GERD, healing of duodenal ulcers, eradication of Helicobacter pylori to reduce duodenal ulcer recurrence, long-term treatment of pathological hypersecretory conditions, and treatment in adolescents aged 12 and older.
    Medication Details
    Drug Interactions

  • esomeprazole magnesium

    (Esomeprazole magnesium)
    Granules Pharmaceuticals Inc.
    Esomeprazole magnesium delayed-release capsules are indicated for the short-term treatment of erosive esophagitis, GERD symptoms, risk reduction of NSAID-associated gastric ulcers, H. pylori eradication, and long-term treatment of pathological hypersecretory conditions, including Zollinger-Ellison syndrome in adults and adolescents aged 12-17.
    Medication Details
    Drug Interactions

  • esomeprazole sodium

    (Esomeprazole Sodium)
    Eugia US LLC
    Esomeprazole sodium for injection is indicated for short-term treatment of gastroesophageal reflux disease with erosive esophagitis in adults and pediatric patients (1 month to 17 years) when oral therapy is inappropriate. It also reduces the risk of rebleeding from gastric or duodenal ulcers after therapeutic endoscopy in adults.
    Medication Details
    Drug Interactions

  • konvomep

    (omeprazole and sodium bicarbonate)
    Azurity Pharmaceuticals, Inc.
    KONVOMEP is indicated for short-term treatment (4 to 8 weeks) of active benign gastric ulcers and for reducing the risk of upper gastrointestinal bleeding in critically ill adult patients.
    Medication Details
    Drug Interactions

  • lansoprazole

    (Lansoprazole)
    Ajanta Pharma USA Inc.
    Lansoprazole delayed-release capsules are indicated for the treatment of active duodenal ulcers, NSAID-associated gastric ulcers, GERD, erosive esophagitis, and for the eradication of H. pylori to prevent duodenal ulcer recurrence. It is also used for maintaining healing of ulcers and treating pathological hypersecretory conditions.
    Medication Details
    Drug Interactions

  • omeprazole

    (OMEPRAZOLE)
    Golden State Medical Supply, Inc.
    Omeprazole is indicated for the short-term treatment of active duodenal ulcers, benign gastric ulcers, GERD symptoms, and erosive esophagitis, as well as for H. pylori eradication to reduce ulcer recurrence. It is also used long-term for pathological hypersecretory conditions like Zollinger-Ellison syndrome.
    Medication Details
    Drug Interactions

  • omeprazole

    (Omeprazole)
    Glenmark Pharmaceuticals Inc., USA
    Omeprazole delayed-release capsules are used for the short-term treatment of active duodenal and benign gastric ulcers, GERD symptoms, erosive esophagitis, and for the eradication of Helicobacter pylori to prevent ulcer recurrence. It's also indicated for the long-term management of pathological hypersecretory conditions in adults.
    Medication Details
    Drug Interactions

  • omeprazole

    (Omeprazole)
    Quallent Pharmaceuticals Health LLC
    Omeprazole delayed-release capsules are indicated for the short-term treatment of active duodenal ulcers, benign gastric ulcers, gastroesophageal reflux disease (GERD), and erosive esophagitis due to GERD. They're also used for Helicobacter pylori eradication and long-term treatment of pathological hypersecretory conditions in adults.
    Medication Details
    Drug Interactions

  • omeprazole

    (Omeprazole)
    Quallent Pharmaceuticals Health LLC
    Omeprazole delayed-release capsules are indicated for short-term treatment of active duodenal and gastric ulcers, symptomatic GERD, erosive esophagitis due to GERD, and long-term management of pathological hypersecretory conditions. They also help eradicate Helicobacter pylori to reduce duodenal ulcer recurrence.
    Medication Details
    Drug Interactions

  • omeprazole

    (Omeprazole)
    Chartwell RX, LLC
    Omeprazole Delayed-Release Capsules are used for treating active duodenal ulcers, benign gastric ulcers, GERD symptoms, erosive esophagitis, maintaining healing of erosive esophagitis, and for pathological hypersecretory conditions. It may also be combined with antibiotics for Helicobacter pylori eradication to reduce ulcer recurrence.
    Medication Details
    Drug Interactions